Letter to the editor regarding “Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomised, double-blind and placebo-controlled study”
Indian Journal of Dermatology, Venereology and Leprology · 2022
DOI: 10.25259/ijdvl_754_2022 ↗Kurz gefasst
Leserbrief in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2022. Verfasst von Rochelle Cheryl Monteiro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Father Muller Medical College Hospital, Mangaluru, Karnataka, India. Hauptthemen laut MEDLINE: Granuloma, Pyogenic, Timolol. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Father Muller Medical College Hospital, Mangaluru, Karnataka, India.
Zitieren
APA
Monteiro, R. C., Shetty, P., Marne, R. B., Mysore, V., & Patil, S. R. (2022). Letter to the editor regarding “Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomised, double-blind and placebo-controlled study”. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_754_2022
Vancouver
Monteiro RC, Shetty P, Marne RB, Mysore V, Patil SR. Letter to the editor regarding “Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomised, double-blind and placebo-controlled study”. Indian Journal of Dermatology, Venereology and Leprology. 2022. doi:10.25259/ijdvl_754_2022
BibTeX
@article{Monteiro2022,
author = {Monteiro, Rochelle Cheryl and Shetty, Prajna and Marne, Ramesh Bhat and Mysore, Venkataram and Patil, Srishti Ravi},
title = {Letter to the editor regarding “Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomised, double-blind and placebo-controlled study”},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2022},
doi = {10.25259/ijdvl_754_2022}
}
EUVIMED